1. Home
  2. EYPT vs BLDP Comparison

EYPT vs BLDP Comparison

Compare EYPT & BLDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EYPT
  • BLDP
  • Stock Information
  • Founded
  • EYPT 1987
  • BLDP 1979
  • Country
  • EYPT United States
  • BLDP Canada
  • Employees
  • EYPT N/A
  • BLDP N/A
  • Industry
  • EYPT Biotechnology: Laboratory Analytical Instruments
  • BLDP Industrial Machinery/Components
  • Sector
  • EYPT Industrials
  • BLDP Energy
  • Exchange
  • EYPT Nasdaq
  • BLDP Nasdaq
  • Market Cap
  • EYPT 579.4M
  • BLDP 479.7M
  • IPO Year
  • EYPT 2005
  • BLDP 1995
  • Fundamental
  • Price
  • EYPT $10.48
  • BLDP $2.13
  • Analyst Decision
  • EYPT Strong Buy
  • BLDP Sell
  • Analyst Count
  • EYPT 8
  • BLDP 11
  • Target Price
  • EYPT $24.75
  • BLDP $1.78
  • AVG Volume (30 Days)
  • EYPT 729.0K
  • BLDP 8.2M
  • Earning Date
  • EYPT 08-06-2025
  • BLDP 08-11-2025
  • Dividend Yield
  • EYPT N/A
  • BLDP N/A
  • EPS Growth
  • EYPT N/A
  • BLDP N/A
  • EPS
  • EYPT N/A
  • BLDP N/A
  • Revenue
  • EYPT $56,042,000.00
  • BLDP $70,668,000.00
  • Revenue This Year
  • EYPT N/A
  • BLDP $43.80
  • Revenue Next Year
  • EYPT N/A
  • BLDP $25.81
  • P/E Ratio
  • EYPT N/A
  • BLDP N/A
  • Revenue Growth
  • EYPT 12.04
  • BLDP N/A
  • 52 Week Low
  • EYPT $3.91
  • BLDP $1.00
  • 52 Week High
  • EYPT $13.99
  • BLDP $2.38
  • Technical
  • Relative Strength Index (RSI)
  • EYPT 59.34
  • BLDP 71.49
  • Support Level
  • EYPT $10.26
  • BLDP $1.80
  • Resistance Level
  • EYPT $11.00
  • BLDP $2.28
  • Average True Range (ATR)
  • EYPT 0.64
  • BLDP 0.13
  • MACD
  • EYPT -0.07
  • BLDP 0.02
  • Stochastic Oscillator
  • EYPT 42.11
  • BLDP 74.58

About EYPT EyePoint Pharmaceuticals Inc.

EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.

About BLDP Ballard Power Systems Inc.

Ballard Power Systems Inc is engaged in design, development, manufacture, sale and service of proton exchange membrane ("PEM") fuel cell products for a variety of applications, focusing on power products for bus, truck, rail, marine, stationary and emerging market (material handling, off-road and other) applications, as well as the delivery of services, including technology solutions, after sales services and training. A fuel cell is an environmentally clean electrochemical device that combines hydrogen fuel with oxygen (from the air) to produce electricity. Key geographical revenue is derived from Poland followed by United States, United Kingdom, and other countries.

Share on Social Networks: